In sharp contrast, Mlkl deletion significantly inhibited cognitive alterations observed in this AD model as the time spent in the target quadrant by MLKL−/− mice treated with Aβo was significantly longer compared to MLKL+/+ mice injected with the oligomers (Fig. 3K). Here, ABO is linked to Alzheimer disease.